Nevro Corp Stock Fundamentals
| NVRO Stock | USD 5.80 0.01 0.17% |
Nevro Corp fundamentals help investors to digest information that contributes to Nevro Corp's financial success or failures. It also enables traders to predict the movement of Nevro Stock. The fundamental analysis module provides a way to measure Nevro Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nevro Corp stock.
At this time, Nevro Corp's Interest Income is very stable compared to the past year. Nevro | Select Account or Indicator |
Nevro Corp Company Return On Equity Analysis
Nevro Corp's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Nevro Corp Return On Equity | -0.43 |
Most of Nevro Corp's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nevro Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Nevro Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Nevro Corp has a Return On Equity of -0.4329. This is 98.19% lower than that of the Health Care Equipment & Supplies sector and 95.04% lower than that of the Health Care industry. The return on equity for all United States stocks is 39.65% higher than that of the company.
Nevro Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nevro Corp's current stock value. Our valuation model uses many indicators to compare Nevro Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nevro Corp competition to find correlations between indicators driving Nevro Corp's intrinsic value. More Info.Nevro Corp is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, Nevro Corp's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nevro Corp's earnings, one of the primary drivers of an investment's value.Nevro Corp's Earnings Breakdown by Geography
Nevro Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nevro Corp's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nevro Corp could also be used in its relative valuation, which is a method of valuing Nevro Corp by comparing valuation metrics of similar companies.Nevro Corp is currently under evaluation in return on equity category among its peers.
Nevro Corp Current Valuation Drivers
We derive many important indicators used in calculating different scores of Nevro Corp from analyzing Nevro Corp's financial statements. These drivers represent accounts that assess Nevro Corp's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Nevro Corp's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 5.8B | 2.8B | 1.4B | 774.3M | 138.0M | 131.1M | |
| Enterprise Value | 6.1B | 3.0B | 1.5B | 891.9M | 294.6M | 279.9M |
Nevro Corp ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Nevro Corp's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Nevro Corp's managers, analysts, and investors.Environmental | Governance | Social |
Nevro Fundamentals
| Return On Equity | -0.43 | ||||
| Return On Asset | -0.0995 | ||||
| Profit Margin | (0.28) % | ||||
| Operating Margin | (0.22) % | ||||
| Current Valuation | 181.19 M | ||||
| Shares Outstanding | 38.37 M | ||||
| Shares Owned By Insiders | 2.87 % | ||||
| Shares Owned By Institutions | 96.98 % | ||||
| Number Of Shares Shorted | 1.82 M | ||||
| Price To Earning | (63.38) X | ||||
| Price To Book | 0.96 X | ||||
| Price To Sales | 0.54 X | ||||
| Revenue | 408.52 M | ||||
| Gross Profit | 269.53 M | ||||
| EBITDA | (126.23 M) | ||||
| Net Income | (113.44 M) | ||||
| Cash And Equivalents | 310.82 M | ||||
| Cash Per Share | 8.78 X | ||||
| Total Debt | 251.16 M | ||||
| Debt To Equity | 0.89 % | ||||
| Current Ratio | 6.65 X | ||||
| Book Value Per Share | 6.11 X | ||||
| Cash Flow From Operations | (19.44 M) | ||||
| Short Ratio | 1.14 X | ||||
| Earnings Per Share | (3.06) X | ||||
| Price To Earnings To Growth | (3.13) X | ||||
| Target Price | 6.53 | ||||
| Number Of Employees | 1.1 K | ||||
| Beta | 0.94 | ||||
| Market Capitalization | 222.56 M | ||||
| Total Asset | 553.84 M | ||||
| Retained Earnings | (812.85 M) | ||||
| Working Capital | 373.06 M | ||||
| Current Asset | 282.63 M | ||||
| Current Liabilities | 36.39 M | ||||
| Net Asset | 553.84 M |
About Nevro Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nevro Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nevro Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nevro Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 1.3 M | 1.3 M | |
| Total Revenue | 408.5 M | 293.2 M | |
| Cost Of Revenue | 139 M | 93.4 M | |
| Stock Based Compensation To Revenue | 0.13 | 0.08 | |
| Sales General And Administrative To Revenue | 0.79 | 0.90 | |
| Research And Ddevelopement To Revenue | 0.13 | 0.12 | |
| Capex To Revenue | 0.02 | 0.02 | |
| Revenue Per Share | 11.01 | 14.56 | |
| Ebit Per Revenue | (0.31) | (0.32) |
Check out Nevro Corp Piotroski F Score and Nevro Corp Altman Z Score analysis. To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nevro Corp. If investors know Nevro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nevro Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.06) | Revenue Per Share | Quarterly Revenue Growth (0.09) | Return On Assets | Return On Equity |
The market value of Nevro Corp is measured differently than its book value, which is the value of Nevro that is recorded on the company's balance sheet. Investors also form their own opinion of Nevro Corp's value that differs from its market value or its book value, called intrinsic value, which is Nevro Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nevro Corp's market value can be influenced by many factors that don't directly affect Nevro Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nevro Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nevro Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nevro Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.